Tesla intends to cease production of its Model S and Model X vehicles and repurpose factory lines to manufacture Optimus humanoid robots. The company is redirecting California manufacturing capacity toward large-scale robotics and autonomy initiatives. This multi-year transition highlights a strategic shift in Tesla's use of facilities and resources.
Tesla, listed on Nasdaq as TSLA, has announced plans to discontinue production of the Model S and Model X, redirecting those factory lines to produce its Optimus humanoid robots. This move involves reallocating manufacturing capacity in California to focus on large-scale robotics and autonomy-driven production. The transition will unfold over several years, representing a significant evolution in how the company deploys its existing facilities and engineering expertise.
This pivot comes amid mixed stock performance for Tesla. Shares closed at $411.11, reflecting a 13.7% increase over the past year and substantial gains over three years. However, recent trends show declines: 4.5% in the past week, 7.6% in the past month, and 6.2% year to date. Investors now view Tesla increasingly as a platform for robotics, AI, and autonomy, beyond its traditional carmaking role. The success of Optimus in manufacturing, software development, and commercial applications will be crucial in evaluating the portion of the current share price tied to non-automotive ventures.
Analyst targets average $418.81, placing the stock price within 2% of consensus. Yet, Simply Wall St's valuation indicates shares trade at 213.2% above estimated fair value, suggesting a premium. Tesla's P/E ratio stands at 406.6, far exceeding the auto industry's average of 23.9. Background factors include recent margin compression, shareholder dilution, and notable insider selling as the company invests in this new direction.
This strategic emphasis on Optimus could reshape investor theses, prioritizing robotics over premium vehicles. Progress on factory retooling and Optimus deployment will be key metrics to watch.
